Bronchial artery embolisation in management of hemoptysis – A retrospective analysis in a tertiary university hospital

Abstract

Our results suggest that BAE is a safe and effective treatment for acute severe and chronic recurrent hemoptysis, supporting the current literature. Besides this, bleeding recurrence was relatively high, and correlated with presence of systemic pulmonary shunting.

Bronchial artery embolization in hemoptysis: a systematic review

“…The most common complications after BAE included transient chest/ back pain and dysphagia which were reported in 1.4%-34.5% and 0.7%-30%, respectively (6,9,11,13,15,16,18,(22)(23)(24)(25)(26)(27). These figures were lower than those reported previously in older reviews and in studies with less than 50 patients (2,3).…”

“…Certain angiographic features such as: a) presence of nonbronchial systemic collaterals, b) bronchopulmonary shunting, and c) incomplete initial embolization were significantly associated with higher recurrence rates (5,12,13,22,23). While a higher recurrence rate has been reported previously in patients with pleural thickening more than 10 mm as it is associated with recruitment of nonbronchial systemic collaterals (30,31), none of the studies in this review observed a significant association between pleural thickening and recurrence.…”

“…We also excluded five studies whose full-texts were not available despite our best efforts. Finally, there were 22 studies (5)(6)(7)(8)(9)(10)(11)(12)(13)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27) meeting the selection criteria for this systematic review. The search strategy is schematized in Fig.…”

“…Furthermore, some authors emphasized that even a small volume of hemoptysis could flood the airspaces in diseased lungs, cause asphyxiation and thus be potentially life-threatening (27). Few studies, instead of grading severity of hemoptysis, described whether BAE was performed in acute massive hemoptysis under emergent conditions or was performed electively for chronic recurrent hemoptysis (13,22). Also, the amount of hemoptysis was not quantified in two studies (11,20).…”

“…Coils provide more proximal occlusion compared with PVA, gelatin sponge, and liquid embolizing agents, and thus were used for embolization of pseudoaneurysms, arteriovenous malformations and nonbronchial systemic collaterals in combination with other embolizing agents (7,9,11,13,20,22,(25)(26)(27).…”